Quantcast
Last updated on April 16, 2014 at 4:54 EDT

Latest Rodenticides Stories

2014-03-26 23:27:31

Lead Investigator Discusses Findings With AJMC, Says Results Show Importance of Self-Testing Plainsboro, NJ (PRWEB) March 26, 2014 The American Journal of Managed Care (AJMC), on Monday published the results of the Self-Testing Analysis Based on Long-Term Experience (STABLE) study. It showed that self-testing significantly improves control of warfarin, as measured by time in therapeutic range (TTR). Results of the study, supported by Alere, were originally shared at the 2012 Scientific...

2014-03-13 00:21:16

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3d7f2f/aluminium) have announced the addition of the "Aluminium phosphide (CAS 20859-73-8) Market Research Report" [http://www.researchandmarkets.com/research/3d7f2f/aluminium ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Aluminium phosphide (CAS 20859-73-8) Market Research Report presents comprehensive data on aluminium...

2014-03-05 14:40:37

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l-year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA. Juan Jesus Carrero, Ph.D., of the Karolinska Institutet, Stockholm, and colleagues...

2014-02-04 12:26:39

The Quest Diagnostics Health Trends(TM) study of 2.7 million test results is the largest to examine warfarin treatment in patients with atrial fibrillation (Afib) treated in primary care and other non-hospital care settings in the United States MADISON, N.J., Feb. 4, 2014 /PRNewswire/ -- Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke or bleeding when treated with the most widely prescribed oral-anticoagulant therapy,...

2013-12-19 11:47:26

Patients with atrial fibrillation – an irregular and often abnormally fast heartbeat – have nearly double the risk of suffering a stroke in the first 30 days after starting to take the anti-clotting drug warfarin compared to non-users, according to a study of over 70,000 patients. The study, published online today (Thursday) in the European Heart Journal, found that the risk was particularly high in the first week after patients started to take the drug. In contrast, once the first 30...

2013-12-18 12:21:30

WASHINGTON, Dec. 18, 2013 /PRNewswire-USNewswire/ -- A national environmental group, Beyond Pesticides, is supporting the U.S. Environmental Protection Agency's (EPA) efforts to protect children by asking national retailers, including Walmart, Target, Home Depot, and Lowe's, to make the holidays safer for children and stop selling dangerous d-CON rodent bait products. Determined by EPA to present unreasonable risks to children and the environment, the 12 products slated for...

2013-10-23 16:30:13

SILVER SPRING, Md., Oct. 23, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCBB: PHRX) (the "Company" or "Pharmagen") today announced that Clotamin® is now available at CVS.com. Clotamin® is a unique and complete multivitamin formulated without vitamin k to meet the special nutritional needs of people taking blood thinning medications (anticoagulants) such as Warfarin. Because it does not contain vitamin k, Clotamin(®) can be taken with Warfarin. Warfarin is the most prescribed...

2013-09-26 08:27:38

SILVER SPRING, Md., Sept. 26, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCBB: PHRX) (the "Company" or "Pharmagen") announces that Clotamin® is now available in over 3000 retail CVS locations. Clotamin® is a unique and complete multivitamin formulated without vitamin k to meet the special nutritional needs of people taking blood thinning medications (anticoagulants) such as Warfarin. Because it does not contain vitamin k, Clotamin(®) can be taken with Warfarin without affecting...

2013-07-25 10:18:45

Selective release of DNA from gold nanorods switches blood clotting on and off Researchers have designed tiny, light-controlled gold particles that can release DNA controls to switch blood clotting off and on. The results are reported July 24 in the open access journal PLOS ONE by Kimberly Hamad-Schifferli and colleagues from the Massachusetts Institute of Technology. The two-way switch for blood clotting relies on the ability of two gold nanoparticles to selectively release different...

2013-07-22 23:01:08

Requests from Fish and Game along with animal rights groups have helped to re-establish laws concerning poisons commonly used to control rodents such as rats and mice. (PRWEB) July 22, 2013 The California Department of Pesticide Regulation (DPR) has new regulations in the works concerning second generation anticoagulant rodenticides (SGARs). The poison baits affected by this new regulation contain the active ingredients of brodifacoum, bromadiolone, difenacoum or difethialone. The...